Computer-based evolutionary search for a nonlinear conversion function for establishing in vitro-in vivo correlation (IVIVC) of oral drug formulations.

Establishment of in vitro-in vivo correlation (IVIVC) accelerates optimization of desirable drug formulations and/or modification of the manufacturing processes in the scale-up and post-approval periods. This article presents a method of finding the optimal conversion function for establishing Level A point-to-point IVIVC, based on a computer-based evolutionary search technique. Gene expression programming (GEP) is a technique for optimizing a mathematical expression tree with the help of a genetic algorithm. A parameter optimization routine, which minimizes the number of parameters in the mathematical expression trees and estimates the best-fit parameter values, was implemented in the GEP algorithm. Feasibility of the computer program was investigated using the in vitro and in vivo data for sustained release diltiazem formulations. It provided a mathematical equation that, from their in vitro dissolution profiles, successfully predicts the plasma concentration profiles of three different formulations of diltiazem following oral administration. Because the present approach does not use intravenous injection data like conventional IVIVC analyses, it is widely applicable to the evaluation of various oral formulations.

[1]  H. Ochs,et al.  Pharmacokinetics and absolute bioavailability of diltiazem in humans , 1984, Klinische Wochenschrift.

[2]  Cândida Ferreira.  Gene Expression Programming in Problem Solving , 2002 .

[3]  Candida Ferreira.  Gene expression programming , 2006 .

[4]  P Timmins,et al.  In‐vitro In‐vivo Correlation Models for Glibenclamide after Administration of Metformin/Glibenclamide Tablets to Healthy Human Volunteers , 2000, The Journal of pharmacy and pharmacology.

[5]  C. M. Reeves,et al.  Function minimization by conjugate gradients , 1964, Comput. J..

[6]  Jelena Parojcić,et al.  Justification of biowaiver for carbamazepine, a low soluble high permeable compound, in solid dosage forms based on IVIVC and gastrointestinal simulation. , 2009, Molecular pharmaceutics.

[7]  Ying Liu,et al.  A Multi‐mechanistic Drug Release Approach in a Bead Dosage Form and In Vitro/In Vivo Correlations , 2003, Pharmaceutical development and technology.

[8]  D. London,et al.  Pharmacokinetics of diltiazem after intravenous and oral administration , 2004, European Journal of Clinical Pharmacology.

[9]  G Levy,et al.  Dissolution rate limited absorption in man. Factors influencing drug absorption from prolonged-release dosage form. , 1965, Journal of pharmaceutical sciences.

[10]  Sreeraj Macha,et al.  In vitro–in vivo correlation for nevirapine extended release tablets , 2009, Biopharmaceutics & drug disposition.

[11]  Chin-Chung Lin,et al.  Correlation of in Vitro Release Rate and in Vivo Absorption Characteristics of Four Chlorpheniramine Maleate Extended-Release Formulations , 1992, Pharmaceutical Research.

[12]  L. Augsburger,et al.  Development and validation of a non‐linear IVIVC model for a diltiazem extended release formulation , 2002, Biopharmaceutics & drug disposition.

[13]  J A Dowell,et al.  Artificial neural networks applied to the in vitro-in vivo correlation of an extended-release formulation: initial trials and experience. , 1999, Journal of pharmaceutical sciences.

[14]  Svetlana Ibrić,et al.  An investigation into the usefulness of generalized regression neural network analysis in the development of level A in vitro-in vivo correlation. , 2007, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[15]  Rosario Lizio,et al.  Modulated release metoprolol succinate formulation based on ionic interactions: in vivo proof of concept. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[16]  Raimar Löbenberg,et al.  Computer simulations using GastroPlus to justify a biowaiver for etoricoxib solid oral drug products. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[17]  Kinam Park,et al.  In vitro-in vivo correlation: perspectives on model development. , 2011, International journal of pharmaceutics.